Answers are grounded in this paper and cite their sources.
Burmannic acid (BURA), a novel Indonesian cinnamon‐derived apocarotenoid, showed antiproliferative effects on oral cancer cells without combined application. The purpose of this study is to assess the potential radiosensitizing ability of BURA in oral cancer cells. ATP assay and flow cytometry were conducted to evaluate the radiosensitizing effects on antiproliferation and anti‐oral cancer mechanisms, with comparisons to normal cells. Combined treatment (x‐ray/BURA), exhibiting normal (S–G) cell safety, shows antiproliferative activity against oral cancer cells, which is alleviated by a ROS inhibitor, N ‐acetylcysteine (NAC). Mechanistically, x‐ray/BURA in oral cancer cells upregulated or activated higher subG1 occurrence, apoptosis (annexin V/caspase‐3), intrinsic/extrinsic caspase‐8/9, cell/mitochondrial ROS, diminishment of mitochondrial membrane potential/glutathione, and oxidative DNA damage than x‐ray, BURA, and that of normal cells. Moreover, NAC partially attenuated these mechanisms. In conclusion, x‐ray/BURA appears to be at least partly ROS‐dependent modulation of radiosensitization and antiproliferative effects in oral cancer cells, with limited adverse impact on normal cells.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: